Word: researching
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...summer, John [B. Owen ’10] and I, we’d basically wake up every morning and go to Widener Library and go to the stacks and read about vampires,” he says. Beyond merely hitting the books, they also engaged in some practical research. A few members of the Lampoon made a trip to Forks in Washington and went on a tour. “We had to live ‘Twilight’ for a while,” Grzecki says...
After all of this research, the Lampoon wrote “Nightlight.” The writers used the “corpse” method, in which they sat at a table and went around saying one word at a time forming the story. After many, many hours of “corpsing” and some editing, the 160 page book was created...
...Shifting Politics That makes the politics - and the lines of political influence - a lot more difficult to sort out. Whereas the traditional pharmaceutical industry is concentrated in just a couple of states, biotech firms have sprung up just about anywhere you find a university with a research hospital, which gives them a broad political base. "I know that vote hurt me at home," says Ohio Senator Sherrod Brown, who led the unsuccessful fight against the 12-year exclusivity in the Senate HELP Committee...
...Indeed, the biologics lobby has become one of K Street's most powerful players. Working largely through BIO and the Pharmaceutical Research and Manufacturers of America (PhRMA), it has funded an extensive network that includes not only lobbyists but also think-tank experts and advocacy groups. "You can't get on the phone with someone who isn't getting paid," says an economist who has studied the biologics issue with funding from a drug company. "They give money to everyone and anyone...
...operating support" from Pfizer and operates out of a small Washington law-firm office. It has been blitzing Capitol Hill with letters arguing that guaranteeing biologics makers fewer than 12 years of exclusivity in the use of their data could cost lives. The other group, the Alliance of Aging Research, is also run by the drug industry. Its chairman is the managing partner of Foxkiser, a drug-company consultant, and its vice chairman is with Novartis...